White label ELPA - ClinicalTrials.eu

Study on Dobutamine and Tocilizumab for Patients with Heart Attack at High Risk of Cardiogenic Shock

Not recruiting

3 1 1
Investigated diseases:
- Cardiac disorder
Investigated drugs:
- Dobutamine
- Tocilizumab
Study on Simvastatin for Preventing Recurrent Pancreatitis in Patients

Not recruiting

3 1 1
Investigated diseases:
- Pancreatitis relapsing
- Pancreatitis acute
Investigated drugs:
- Simvastatin
- Lactose Monohydrate
Study on Botulinum Toxin Type A to Prevent Pancreatic Fistulas in Patients Undergoing Distal Pancreatectomy

Not recruiting

2 1 1 1
Investigated diseases:
- Pancreatic fistula
Investigated drugs:
- Botulinum Toxin Type A
Study of Nivolumab and Relatlimab for Adults with Advanced or Metastatic Soft-Tissue Sarcoma

Not recruiting

2 1 1 1
Investigated diseases:
- Soft tissue sarcoma
Investigated drugs:
- Nivolumab
- Relatlimab
Study on Ceralasertib, Oleclumab, and Monalizumab for Advanced Non-Small Cell Lung Cancer Patients Resistant to PD-1 Inhibitors

Not recruiting

2 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
Study of decitabine and cedazuridine combination in patients with lower-risk myelodysplastic syndromes

Not recruiting

1 1 1
Investigated diseases:
- Myelodysplastic syndrome
Investigated drugs:
- Cedazuridine
- Decitabine
Study on the Safety and Effectiveness of Azacitidine and Venetoclax for Patients with Higher-Risk Chronic Myelomonocytic Leukemia (CMML)

Not recruiting

2 1 1 1
Investigated drugs:
- Azacitidine
- Venetoclax
Study on the Effects of Atezolizumab, Trastuzumab, and Pertuzumab in Patients with Early-Stage Triple-Negative or HER2+ Breast Cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Triple negative breast cancer
- HER2 positive breast cancer
Investigated drugs:
Study on the Effect of Low-Dose Aspirin in Preventing New or Recurrent Colorectal Polyps in Patients with Lynch Syndrome

Not recruiting

3 1 1
Investigated diseases:
- Colorectal adenoma
- Hereditary non-polyposis colorectal cancer syndrome
Investigated drugs:
- Acetylsalicylic Acid
Study of dose reduction strategy for tyrosine kinase inhibitors (imatinib, ponatinib, bosutinib, nilotinib, dasatinib) in patients with chronic myeloid leukemia

Not recruiting

3 1 1 1
Investigated diseases:
- Chronic myeloid leukaemia
Investigated drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies